Fractyl Health, Inc.
GUTS
$1.50
-$0.13-7.98%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -78.57% | -67.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -78.57% | -67.44% | |||
| Cost of Revenue | -100.00% | -70.83% | |||
| Gross Profit | -57.14% | -63.16% | |||
| SG&A Expenses | 2.81% | -23.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.90% | 3.39% | |||
| Operating Income | -5.95% | -3.52% | |||
| Income Before Tax | -7.75% | -34.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.75% | -34.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.75% | -34.50% | |||
| EBIT | -5.95% | -3.52% | |||
| EBITDA | -5.94% | -3.47% | |||
| EPS Basic | -6.71% | -34.28% | |||
| Normalized Basic EPS | -15.71% | -21.33% | |||
| EPS Diluted | -6.71% | -34.28% | |||
| Normalized Diluted EPS | -15.71% | -21.33% | |||
| Average Basic Shares Outstanding | 0.98% | 0.16% | |||
| Average Diluted Shares Outstanding | 0.98% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||